C1-inhibitor attenuates neurobehavioral deficits and reduces contusion volume after controlled cortical impact brain injury in mice

Crit Care Med. 2009 Feb;37(2):659-65. doi: 10.1097/CCM.0b013e318195998a.

Abstract

Objective: The aim of the study was to evaluate the effects of C1-inhibitor (C1-INH), an endogenous inhibitor of complement and kinin systems, on neurobehavioral and histological outcome following controlled cortical impact brain injury.

Design: Experimental prospective randomized study in mice.

Setting: Experimental laboratory.

Subjects: Male C57Bl/6 mice (n = 81).

Interventions: Mice were subjected to controlled cortical impact brain injury followed by an intravenous bolus of either C1-INH (15 U either at 10 minutes or 1 hour postinjury) or saline (equal volume, 150 microl at 10 minutes postinjury). Sham-operated mice received identical surgery and saline injection without brain injury. Neurological motor function was evaluated weekly for 4 weeks using the Composite Neuroscore. Cognitive function was evaluated at 4 weeks postinjury using the Morris Water Maze. Histological outcome was performed by measuring the contusion volume at 1 week and 4 weeks postinjury.

Measurements and main results: Brain-injured mice receiving C1-INH at 10 minutes postinjury showed attenuated motor deficits, cognitive dysfunction and reduced contusion volume compared to brain-injured mice receiving saline. Mice receiving C1-INH at 1 hour postinjury showed reduced motor deficits compared to brain-injured mice receiving saline, but no significantly different cognitive and histological outcome. Immunohistochemical analysis showed that 20 minutes after infusion, C1-INH was localised on endothelial cells and in brain tissue surrounding brain capillaries of the injured hemisphere.

Conclusion: Our results show that post-traumatic administration of C1-INH attenuates neuro-behavioral deficits and histological damage associated with traumatic brain injury.

MeSH terms

  • Animals
  • Behavior, Animal / drug effects*
  • Brain Injuries / drug therapy*
  • Brain Injuries / prevention & control*
  • Brain Injuries / psychology
  • Complement C1 Inhibitor Protein / pharmacology
  • Complement C1 Inhibitor Protein / therapeutic use*
  • Immunohistochemistry
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Prospective Studies

Substances

  • Complement C1 Inhibitor Protein
  • Serping1 protein, mouse